PrimeRFP SCOUT · Federal Contract Recompete Brief

75N94025P00590 — NIDDK: SUPPLY: ONGOING COLLABORATION TO PURCHASE ENANTIOMERS OF CYCLOPENTANEDIAMINE AND TETRAHYDRO - SEVERABLE

NIDDK: SUPPLY: ONGOING COLLABORATION TO PURCHASE ENANTIOMERS OF CYCLOPENTANEDIAMINE AND TETRAHYDRO - SEVERABLE is a federal NONE award for Department of Health and Human Services (HHS) held by CYCLOPE BIO SL. Estimated value $140K ($140K obligated). Current period of performance ends Sep 10, 2026. Last award drew 1 bidder. Related solicitation 75N94025Q00201.

$140K
Estimated Value
Sep 10, 2026
PoP End / Expires
1
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

CYCLOPE BIO SL holds $239K across 2 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 10, 2026 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75N94025P00590
AgencyDepartment of Health and Human Services (HHS)
IncumbentCYCLOPE BIO SL
CAGE9B5SB
UEIK929DS87AWG9
NAICS325199

No full NAICS 325199 intel page yet. Browse NAICS intelligence

PSC6810
Pricing typeFirm Fixed Price
Extent competedNot Competed Under SAP
Related solicitation75N94025Q00201
PoP startSep 11, 2025
PoP end (current)Sep 10, 2026
Obligated$140K
Current value$140K
Potential value$140K

NIDDK: SUPPLY: ONGOING COLLABORATION TO PURCHASE ENANTIOMERS OF CYCLOPENTANEDIAMINE AND TETRAHYDRO - SEVERABLE

Recompete timing

Public
Expiring in 21 days

Current PoP ends Sep 10, 2026 (21 days remaining). Agencies typically plan 12–18 months ahead — at 0.7 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

CYCLOPE BIO SL$239K obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$239K · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 75N94025P00590
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open CYCLOPE BIO SL’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75N94025P00590?

75N94025P00590 (NIDDK: SUPPLY: ONGOING COLLABORATION TO PURCHASE ENANTIOMERS OF CYCLOPENTANEDIAMINE AND TETRAHYDRO - SEVERABLE) is a Department of Health and Human Services (HHS) award with an estimated value of $140K, currently held by CYCLOPE BIO SL. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75N94025P00590?

CYCLOPE BIO SL is the incumbent with $239K across 2 related awards in SCOUT’s public footprint. The current period of performance ends Sep 10, 2026.

When does 75N94025P00590 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 10, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N94025P00590

SCOUT Signal

August 2026

One VA health contract was 35% of civilian federal obligations in July.

Meanwhile VA's service-disabled veteran-owned contract actions fell 41.8%. The same agency, the same month, the large-vendor lane expanding while the small-business lane contracted. Figures are civilian-agency obligations through 2026-07-31; DoD FPDS for this window is labeled incomplete.

This issue is the whole civilian market. Your capture plan isn't.

Read the August 2026 issue →